Stelios T. Andreadis Associate Professor 908 Furnas Hall (716) 645-2911 ext. 2204 Fax: (716) 645-3822 sandread@buffalo.edu

Short bio

Research

Publications

Teaching

Chapters in Books

• S.T. Andreadis (2006) Gene therapy for tissue regeneration In “Biodegradable polymeric materials and their applications ” , S.K. Mallapragada and B. Narasimhan (Eds), American Scientific Publishers, Chapter 7: 125-140.

• S.T. Andreadis (2006) Gene therapy in tissue engineering of skin: the next generation skin substitutes In “Tissue Engineering II ” , Kyongbum Lee and David Kalpan (Eds.), Springer Verlag, 241-274.

• Kyongbum Lee and David Kalpan (Eds), Springer Verlag.S.T. Andreadis (2003) Gene Enhanced Tissue Engineering, In “Biomedical Technology and Devices Handbook” , James Moore and George Zouridakis (Eds), CRC Press, Chapter 19: 1-27.

• S.T. Andreadis (2002) Methods for the Quantitative Measurement of the Concentration of Active Recombinant Retrovirus.  In "Gene Therapy Protocols" 2nd Edition, J.R. Morgan (Ed.), Humana Press, Chapter 13; 161-172.

Patents

• Dan Swartz and Stelios T. Andreadis, “Fibrin-based tissue engineered vasculature” Filed in the U.S. Patent and Trademark Office on October 23, 2003 by the Research Foundation of the State University of New York, U.S. Patent Application Serial No. 10/692,381.

• D.J. Geer and Stelios T. Andreadis, “Conjugation and controlled delivery of growth factors through fibrin gels”, Filed in the U.S. Patent and Trademark Office in November 17, 2003 by the Research Foundation of the State University of New York as a Provisional Patent Application, Serial Number 60/520,697.

• Pedro Lei and Stelios T. Andreadis, “Tissue engineered insulin releasing skin grafts for treatment of diabetes”, Filed in the U.S. Patent and Trademark Office in October 15, 2004 by the Research Foundation of the State University of New York as a Provisional Patent Application, Serial Number 60/619,228.

Refereed Journal Publications

• P. Lei and S.T. Andreadis (2007)  Efficient retroviral gene transfer to epidermal stem cells, Methods Mol. Med.  In Press.

• J. Liu, D.D. Swartz, S.F. Gugino, L. Yao, J.A. Russell and S.T. Andreadis (2007)  Engineering blood vessels from bone marrow stem cells  Cardiovasc. Res.  In Press.

• K.G. Cornwell, P. Lei, S.T. Andreadis and G.D. Pins (2007)  Crosslinking of discrete self-assembled collagen threads:  effects on mechanical strength and cell-matrix interactions  J. Biomed. Mater. Res. A. 80(2): 362-371.

• S.T. Andreadis (2007)  Gene-modified tissue-engineered skin:  the next generation of skin substitutes  Adv. Biochem. Eng. Biotechnol. 103: 241-74.

• P. Lei, A. Ogunade, K.L. Kirkwood, S.G. Laychock and S.T. Andreadis (2007)  Efficient production of bioactive insulin from human epidermal keratinocytes and tissue engineered skin substitutes:  implications for treatment of diabetes  Tissue Eng.  Jan. 1;  [Epub ahead of print].

• R. Singh and S.T. Andreadis (2007)  EGF receptor activation decreases retroviral gene transfer through protein kinase C delta  Mol. Ther. 15(2): 369-377.

• P. Koria and S.T. Andreadis (2006) Epidermal morphogenesis:  the transcriptional program of human keratinocytes during stratification  J. Invest. Dermatol. 126(8): 1834-41.

• S.T. Andreadis and D.J. Geer (2006)  Biomimetic approaches to protein and gene delivery for tissue regeneration   Trends Biotechnol. 24(7): 331-337.

• S.T. Andreadis (2006)  Experimental models and high throughput diagnostics for tissue regeneration  Expert Opin. Biol. Ther. 6(11): 1071-86.

• B.G. Bajaj, P. Lei and S.T. Andreadis (2005) Efficient gene transfer to human epidermal keratinocytes: in vitro evidence for transduction of epidermal stem cells Mol. Ther. 11(6): 969-979.

• P. Lei and S.T. Andreadis (2005) Stoichiometric limitations in assembly of active recombinant retrovirus Biotechnol. Bioeng. 90(7): 781-92.

• D.D. Swartz, J.A. Russell and S.T. Andreadis (2005) Tissue engineering of functional and aimplanatable small diameter blood vessels Am. J. Physiol. Heart and circulatory Physiology 288(3): H1451-1460.

• L. Yao, D.D. Swartz, Sylvia Guigino, J.A. Russell, and S.T. Andreadis (2005) Fibrin-based tissue engineered blood vessels:  differential effects of biomaterial and culture parameters on mechanical strength and vasoreactivity Tissue Eng. 11(7-8): 991-1003.

• D.J. Greer, D.D. Swartz and S.T. Andreadis (2005)  Biomimetic delivery of KGF upon cellular demand for accelerated wound heating in vitro and in vivo Am. J. Pathol. 167(6):  1575-86.

• F. Hua, L. Yao, S.T. Andreadis and E. Ruckenstein (2005)  Biocompatible conducting PLLA or PLGA-grafted polyaniline as novel cell-culture substrates PMSE Preprints 93: 721-722.

• S.T. Andreadis (2004) Gene transfer to epidermal stem cells: implications for tissue engineering Expert Opinion on Biological Therapy 4(6): 1-18.

• D.J. Geer, D.D. Swartz and S.T. Andreadis (2004) An in vivo model of wound healing based on transplanted tissue engineered skin Tissue Engr. 10(7-8): 28-37.

• D.J. Geer and S.T. Andreadis (2003) A novel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes J. Invest. Dermatol. 121(5): 1210-1216.

• K.L. Kirkwood, T. Martin, S.T. Andreadis and Y.J. Kim (2003) Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability Biochem Pharmacol 66(9): 1809-19.

• P. Koria, D. Brazeau, K.L. Kirkwood, P. Hayden, M. Klausner, and S.T. Andreadis (2003) Gene expression profile of tissue engineered skin subjected to acute barrier disruption J. Invest. Dermatol. 121(2): 368-382.

Last Updated: October 2007